{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-331512","form_type":"8-K","ticker":"ODTX","cik":"0001882782","company_name":"Odyssey Therapeutics, Inc.","filed_at":"2026-08-04T11:00:16+00:00","discovered_at":"2026-08-04T11:05:00.386483+00:00","generated_at":"2026-08-04T11:06:36.578725+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Odyssey Therapeutics Q2 2026 net loss $52.8M; cash $433.1M; OD-001 data at UEG Week","bullets":["Net loss $52.8M for Q2 2026 vs $41.2M in Q2 2025; adjusted net loss (non-GAAP) $38.4M.","Cash, cash equivalents and marketable securities $433.1M as of June 30, 2026; expected to fund operations into 2H 2028.","R&D expenses $36.2M (up from $30.2M); G&A $10.5M (down from $13.2M).","OD-001 Phase 2a data accepted for oral presentation at UEG Week in October; Phase 2b monotherapy and Phase 2a combo with vedolizumab expected to initiate in 2H 2026.","OD-002 (SLC15A4 inhibitor) CTA filing expected in 2H 2026; Phase 1/2a trial initiation in 1H 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-331512","json":"https://secwatch.observer/filing/0001193125-26-331512.json","markdown":"https://secwatch.observer/filing/0001193125-26-331512.md","text":"https://secwatch.observer/filing/0001193125-26-331512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526331512/0001193125-26-331512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526331512/odtx-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T11:06:36.578725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}